Provider Alert! Generic for Rapumune Tablets and Solutions (Sirolimus) Now Preferred
Date: February 16, 2024 Attention: All Providers Effective: February 12, 2024 Call to action: Texas Children’s Health Plan (TCHP) would like to let providers know that effective February 12, 2024, sirolimus tablets and generics will now be preferred. This is in response to the discontinuation of the brand product Rapamune by the manufacturer. How this impacts providers: The change will allow providers to prescribe the generic without requiring Preferred Drug List (PDL) prior authorization at this time and continue accessing necessary medication for their...
